Redeye: Proact - Encouraging Improvements in Margins
Redeye raises its Base Case and forecasts following a strong Q1 report, with the strong gross margin, high new cloud contracts intake, and solid ARR growth being the highlights. While the System sales mix plays a role in the strong gross margin, underlying efficiency improvements also drove the solid number. Proact is close to its 8% EBITA margin target for the first time.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/